Stocks making the biggest moves after hours: CRISPR Therapeutics, Box and more
https://www.cnbc.com/2018/05/30/after-hours-buzz-crsp-box-more.html
Check out the companies making headlines after the bell on Wednesday:
Shares of CRISPR Therapeutics plunged 18.5 percent in extended trading. The biotechnology company disclosed that the FDA has placed a clinical hold on its drug application for a sickle cell disease stem cell therapy. The suspension will be in effect until CRISPR and Vertex Pharmaceuticals answer FDA questions about the drug application.
Stocks making the biggest moves after hours: CRISPR Therapeutics, Box and more
May 30, 2018, 10:27pm UTC
https://www.cnbc.com/2018/05/30/after-hours-buzz-crsp-box-more.html
> Check out the companies making headlines after the bell on Wednesday:
> Shares of CRISPR Therapeutics plunged 18.5 percent in extended trading. The biotechnology company disclosed that the FDA has placed a clinical hold on its drug application for a sickle cell disease stem cell therapy. The suspension will be in effect until CRISPR and Vertex Pharmaceuticals answer FDA questions about the drug application.